News and insights

Company news, science and development updates.

Announcements from Komava Biotherapeutics, and perspectives on the science of regenerative wound care.

Press release 1 July 2026

Komava Biotherapeutics Launches to Advance Regenerative Therapies for Chronic Wounds

Komava Biotherapeutics has launched as a preclinical-stage biotechnology company developing a bacterial cellulose platform for regenerative treatment of chronic wounds.

Read the press release

Let’s advance regenerative wound care.

We welcome discussions with biotechnology and pharmaceutical companies, scientific collaborators, development organisations and investors interested in advancing the Komava platform.

Contact Komava Media enquiries